http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020075790-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate 2019-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a96cdae884ee533d1e195dc809e94c8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4ff7f66159630ec85563e31294bb8f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39e477cb6a03368cc04c7f2c475e334f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64c7c90f63a893ae084b05a740101b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d2b6d81a61a65754ce6a445e1af765c
publicationDate 2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020075790-A1
titleOfInvention Sting-agonist compound
abstract The present invention addresses the problem of providing a pharmaceutical product containing, as an active ingredient, a compound having agonistic activity to STING. As a result of extensive investigations, the inventors of the present invention have discovered, as substances capable of solving the problem, compounds represented by general formula (I-1) [all of the symbols in the formula are as described in the description] and having agonistic activity to STING, thereby arriving at the present invention. The compounds represented by general formula (I-1) according to the present invention have agonistic activity to STING, and can thus be used as active ingredients of agents for treating, suppressing the progress of, and/or suppressing the recurrence of cancer or infectious diseases.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021206160-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022086260-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021205631-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022229341-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023280227-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022226317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022217022-A1
priorityDate 2018-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017202273-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016126646-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006007448-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016077518-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016149351-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016100285-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017176608-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017186711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015034820-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017175156-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008156712-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014151634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017112730-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017192961-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017087777-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016057624-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017202274-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017070089-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017205464-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017066227-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007005874-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017146519-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017151830-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017106740-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0114424-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017118762-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2868691-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018067423-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017093933-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3095355-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018516903-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015160641-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006121168-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017106634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017202276-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016039749-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017050967-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017202275-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016100608-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452462218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467028762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153562047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454030351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118658141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153562061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432551266

Total number of triples: 83.